Anisometric particles for the pulmonary application of active agents
Inhalation therapy provides any advantages in comparison to the oral or intravenous application of drugs Pharmaceutically active agents can very often be applied to the site of action in a more targeted manner by means of inhalation, whereby the dose can be reduced in comparison to other application formulations and side effects can be lowered.<br><br>
In many cases, particles of the active agent have to be packed within suitable carrier molecules. Carrier molecules known so far are mostly spherical, and this spherical nature prevents the particles from achieving certain lung areas.<br><br> By contrast, the invention at hand provides for procedures for the manufacturing of inhalable particles from biocompatible polymers that are not spherical, but anisometric. Furthermore, diameter and length are specifically adjustable, and the particles may feature structured surfaces and/or pore- or pearl-like recesses. Thus it is possible to produce particles which can be specifically deposited within particular lung areas and which release the active agent in a retarded manner.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans
The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…